← Back to search
CERAMEDIX HOLDING, LLC
NEW YORK, NY, 10022
UnclaimedClaim this profile (free)
Prime contracting experience
3 records from government sources. Past participation is not evidence of current teaming interest.
| Role | Agency | Description | Vehicle | Obligated | Action date | Period |
|---|---|---|---|---|---|---|
| Prime | Department of Health and Human Services National Institutes of Health | DEVELOPMENT OF ANTICERAMIDE TREATMENT AS A NOVEL MEDICAL COUNTERMEASURE FOR ACUTE EFFECTS OF RADIATION EXPOSURE | — | $4,223,612 | Jul 20, 2026 | Jul 1, 2023 – Jun 30, 2027 |
| Prime | Department of Health and Human Services National Institutes of Health | DEVELOPMENT OF RADIATION/NUCLEAR MEDICAL COUNTERMEASURES (MCMS) AND BIODOSIMETRY DEVICES. 7-1/2026 TO 6/30/2026. DAP-NCAP-00000073. | — | $1,500,000 | Jun 24, 2026 | Jul 1, 2026 – Jun 30, 2027 |
| Prime | Department of Defense Defense Health Agency | JW190496 FY19 NEW START | — | $4,496,897 | Jul 10, 2023 | Sep 28, 2020 – Sep 27, 2024 |
Contract vehicles are shown only when present in the source record. Linked award numbers and vehicles open the authoritative record on USAspending.gov.
Agencies supported
- Department of Health and Human ServicesGov-sourced
- Department of DefenseGov-sourced
Government-sourced data comes from SAM.gov, SBA and USAspending.gov and is attributed to its source. Items marked company-reported were provided by the company and are verified by FedSub only where labeled. FedSub is a private company and is not affiliated with SBA, GSA/SAM.gov, or any government agency.